drugset / Trial / NCT00817895

Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

NCT00817895

RandomizedParallel-groupOpen-labelPrevention

Summary

Hepatectomy is still the most important treatment for HCC.High recurrence rate mostly influence it's prognosis, especially for the patient with tumor \>5cm, multiple tumor and who cannot accept R0 resection.Our retrospective study showed sustained released 5-FU implanted into the liver incisal margin after tumor was resected could reduce the recurrence rate of HCC after liver resection.According to this, we proceed this RCT to prospectively observe the effect of sustained released 5-FU,and we also want to know whether combined with sustained released cisplatin will get better effect in preventing the tumor recurrence,especially in short time after liver resection.

Timeline

Start
2008-12
Primary completion
2009-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 60 mg Other
Comparator fluorouracil Small molecule 600 mg Other